• Email:sales@AmericanPharmaWholesale.com
  • Site Map




Please email us at Sales@AmericanPharmaWholesale.com with our item No, NDC#, UPC# or best is product link. We are located in Oceanside, California. Search over 100,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name.


Menu

RX ITEM-Ocrevus ocrelizumab 30Mg/Ml (300 Mg) Singledose Presrv Free Vial 1X10 Ml

item No.:RX68982-0141-01 NDC No.68982-0141-01 68982-141-01 6898214101 68982014101  68982014101  UPC No.:368982141013 3-68982-14101-3 368982-141013 Item No.:014101BRAND: OCREVUS NDC: RX68982-0141-01 ,RX68982014101  UPC: 368982-141013,368982141013  Generic Name:
OCRELIZUMAB

 Description:
OCREVUS 30MG/ML, (300 MG), SINGLEDOSE PRESRV FREE VIAL, 1X10 ML
 Alt Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scopWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

RX ITEM-Ocrevus ocrelizumab 30Mg/Ml (300 Mg) Singledose Presrv Free Vial 1X10 Ml

$19500.00$17842.50

item No.:RX68982-0141-01 NDC No.68982-0141-01 68982-141-01 6898214101 68982014101 68982014101 UPC No.:368982141013 3-68982-14101-3 368982-141013 Item No.:014101 Generic Name:
OCRELIZUMAB
Description:
OCREVUS 30MG/ML, (300 MG), SINGLEDOSE PRESRV FREE VIAL, 1X10 ML
Alt Item #:
5341664
NDC:
50242-0150-01
UPC:
350242-150019
Contract:
Contract Alias:
Strength:
30MG/ML
Form:
SINGLEDOSE PRESRV FREE VIAL
Size:
1X10 ML Only Lic.-Physician,Phar

Have a question?

These highlights do not include all the information needed to use OCREVUS safely and effectively. See full prescribing information for OCREVUS. OCREVUS� (ocrelizumab) injection, for intravenous use Initial U.S. Approval: 2017 INDICATIONS AND USAGE OCREVUS is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis (1) DOSAGE AND ADMINISTRATION Hepatitis B virus screening is required before the first dose (2.1) Pre-medicate with methylprednisolone (or an equivalent corticosteroid) and an antihistamine (e.g., diphenhydramine) prior to each infusion (2.2) Administer OCREVUS by intravenous infusion Start dose: 300 mg intravenous infusion, followed two weeks later by a second 300 mg intravenous infusion (2.3) Subsequent doses: 600 mg intravenous infusion every 6 months (2.3) Must be diluted prior to administration (2.3, 2.6) Monitor patients closely during and for at least one hour after infusion (2.3, 2.5) DOSAGE FORMS AND STRENGTHS Injection: 300 mg/10 mL (30 mg/mL) in a single-dose vial. (3) CONTRAINDICATIONS Active hepatitis B virus infection (4) History of life-threatening infusion reaction to OCREVUS (4) WARNINGS AND PRECAUTIONS Infusion reactions: Management recommendations for infusion reactions depend on the type and severity of the reaction. Permanently discontinue OCREVUS if a life-threatening or disabling infusion reaction occurs (2.3, 5.1) Infections: Delay OCREVUS administration in patients with an active infection until the infection is resolved. Vaccination with live-attenuated or live vaccines is not recommended during treatment with OCREVUS and after discontinuation, until B-cell repletion (5.2) Malignancies: An increased risk of malignancy, including breast cancer, may exist with OCREVUS (5.3) ADVERSE REACTIONS The most common adverse reactions were: RMS (incidence ?10% and > REBIF): upper respiratory tract infections and infusion reactions (6.1) PPMS (incidence ?10% and > placebo): upper respiratory tract infections, infusion reactions, skin infections, and lower respiratory tract infections (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Genentech at 1-888-835-2555 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. USE IN SPECIFIC POPULATIONS Pregnancy: Based on animal data, may cause fetal harm. (8.1) See 17 for PATIENT COUNSELING INFORMATION and Medication Guide. Revised: 3/2017

item No.:RX68982-0141-01 NDC No.68982-0141-01 68982-141-01 6898214101 68982014101  68982014101  UPC No.:368982141013 3-68982-14101-3 368982-141013 Item No.:014101
RX ITEM-Ocrevus 30Mg/Ml (300 Mg) Singled
item No.:RX68982-0141-01 NDC No.68982-0141-01 68982-141-01 6898214101 68982014101 68982014101 UPC No.:368982141013 3-68982-14101-3 368982-141013 Item No.:014101

BRAND: OCREVUS NDC: RX68982-0141-01 ,RX68982014101  UPC: 368982-141013,368982141013  Generic Name:
OCRELIZUMAB

 Description:
OCREVUS 30MG/ML, (300 MG), SINGLEDOSE PRESRV FREE VIAL, 1X10 ML
 Alt
Ocrevus 30Mg/Ml (300 Mg) Singledose Pres
BRAND: OCREVUS NDC: RX68982-0141-01 ,RX68982014101 UPC: 368982-141013,368982141013 Generic Name: OCRELIZUMAB Description: OCREVUS 30MG/ML, (300 MG), SINGLEDOSE PRESRV FREE VIAL, 1X10 ML Alt

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
American Pharma Wholesale
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.